Nov 06, 2020
Mylan Announces Third Quarter 2020 Financial Results and Looks Ahead to the Launch of Viatris Inc.
Nov 02, 2020
Mylan Announces Appointment of Experienced Pharmaceutical Executive Bill Szablewski as Head of Capital Markets for Viatris
Oct 30, 2020
Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn
Sep 09, 2020
Mylan to Present at the Morgan Stanley Virtual 18th Annual Global Healthcare Conference
Sep 09, 2020
Mylan to Present at the BofA Securities Virtual Global Healthcare Conference
Sep 08, 2020
Mylan to Acquire Aspen's Thrombosis Business in Europe
Aug 31, 2020
Mylan and Biocon Biologics Announce Launch of Semglee(TM) (insulin glargine injection) in the U.S. to Expand Access for Patients Living with Diabetes
Aug 28, 2020
Mylan Initiates Voluntary Nationwide Recall of Four Lots of Amiodarone HCl Injection, USP and Tranexamic Acid Injection, USP Due to Carton Label Mix-Up
Aug 19, 2020
Mylan Brings Critical Access to the Multiple Sclerosis Community by Launching a More Affordable Treatment Option Through a First Generic to Tecfidera®
Aug 12, 2020
Mylan and Sesame Workshop Partner to Provide Socio-Emotional Support Resources to Families Impacted by COVID-19
Aug 06, 2020
Mylan Reports Strong Second Quarter and First Half 2020 Results and Updates 2020 Guidance
Jul 22, 2020
Mylan to Release Second Quarter 2020 Financial Results on Aug. 6, 2020
Jul 09, 2020
Mylan and Fujifilm Kyowa Kirin Biologics Announce U.S. FDA Approval of Hulio® (adalimumab-fkjp)
Jul 09, 2020
Viatris Reveals Branding to Reflect New Company's Transformative Strategy
Jul 07, 2020
Mylan Initiates Voluntary Nationwide Recall of One Lot of Daptomycin for Injection, Due to the Presence of Particulate
Jul 06, 2020
Mylan Secures Regulatory Approval for Remdesivir Lyophilized Powder for Injection 100 mg/vial in India for Restricted Emergency Use in COVID-19 Patients
Jun 30, 2020
Mylan Shareholders Overwhelmingly Approve Proposed Combination with Upjohn
Jun 04, 2020
Mylan and Lupin Receive European Marketing Authorization for Nepexto®, Biosimilar Etanercept
May 29, 2020
Mylan Invalidates Sanofi's Lantus® SoloSTAR® Device Patents in IPR Proceedings
May 13, 2020
Mylan to Present at the 2020 RBC Capital Markets' Virtual Global Healthcare Conference